Autopsy report · NCT03150056
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
Cause of deathFutility
“This study has been terminated due to meeting protocol defined futility.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 11 months before it stopped.
- 73 participants enrolled.
- Results were posted on the registry 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Solid Tumours
- Interventions
- GSK525762; Abiraterone; Enzalutamide; Prednisone
- Participants
- 73
- Sites
- 20
- Countries
- Australia, Spain, United Kingdom, United States
Trials that died the same way
- An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
“This study met a protocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.” - Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
“This study was terminated early due to futility.” - Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
“This trial was terminated following a futility analysis confirming futility of continuing the study” - Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
“The study was terminated due to excessive toxicity and low compliance to the protocol scheme.” - Trial to Evaluate UltraSound in the Treatment of Tibial Fractures
“Study was terminated due to futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.